Literature DB >> 29769197

Cancer-Associated Fibroblasts Drive Glycolysis in a Targetable Signaling Loop Implicated in Head and Neck Squamous Cell Carcinoma Progression.

Dhruv Kumar1, Jacob New1,2, Vikalp Vishwakarma1, Radhika Joshi3, Jonathan Enders2, Fangchen Lin3, Sumana Dasari3, Wade R Gutierrez1, George Leef3, Sivapriya Ponnurangam4, Hemantkumar Chavan5, Lydia Ganaden1, Mackenzie M Thornton1, Hongying Dai6, Ossama Tawfik7, Jeffrey Straub1, Yelizaveta Shnayder1, Kiran Kakarala1, Terance Ted Tsue1, Douglas A Girod1, Bennett Van Houten8, Shrikant Anant4,9, Partha Krishnamurthy5, Sufi Mary Thomas10,2,9.   

Abstract

Despite aggressive therapies, head and neck squamous cell carcinoma (HNSCC) is associated with a less than 50% 5-year survival rate. Late-stage HNSCC frequently consists of up to 80% cancer-associated fibroblasts (CAF). We previously reported that CAF-secreted HGF facilitates HNSCC progression; however, very little is known about the role of CAFs in HNSCC metabolism. Here, we demonstrate that CAF-secreted HGF increases extracellular lactate levels in HNSCC via upregulation of glycolysis. CAF-secreted HGF induced basic FGF (bFGF) secretion from HNSCC. CAFs were more efficient than HNSCC in using lactate as a carbon source. HNSCC-secreted bFGF increased mitochondrial oxidative phosphorylation and HGF secretion from CAFs. Combined inhibition of c-Met and FGFR significantly inhibited CAF-induced HNSCC growth in vitro and in vivo (P < 0.001). Our cumulative findings underscore reciprocal signaling between CAF and HNSCC involving bFGF and HGF. This contributes to metabolic symbiosis and a targetable therapeutic axis involving c-Met and FGFR.Significance: HNSCC cancer cells and CAFs have a metabolic relationship where CAFs secrete HGF to induce a glycolytic switch in HNSCC cells and HNSCC cells secrete bFGF to promote lactate consumption by CAFs. Cancer Res; 78(14); 3769-82. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29769197      PMCID: PMC6050074          DOI: 10.1158/0008-5472.CAN-17-1076

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  54 in total

Review 1.  Metabolic control through the PGC-1 family of transcription coactivators.

Authors:  Jiandie Lin; Christoph Handschin; Bruce M Spiegelman
Journal:  Cell Metab       Date:  2005-06       Impact factor: 27.287

2.  Differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal human adult tissues.

Authors:  S E Hughes
Journal:  J Histochem Cytochem       Date:  1997-07       Impact factor: 2.479

3.  Fibroblast growth factor-2 gene transfer can stimulate hepatocyte growth factor expression irrespective of hypoxia-mediated downregulation in ischemic limbs.

Authors:  Mitsuho Onimaru; Yoshikazu Yonemitsu; Mitsugu Tanii; Kazunori Nakagawa; Ichiro Masaki; Shinji Okano; Hiroaki Ishibashi; Kanemitsu Shirasuna; Mamoru Hasegawa; Katsuo Sueishi
Journal:  Circ Res       Date:  2002-11-15       Impact factor: 17.367

4.  Glucose, not glutamine, is the dominant energy source required for proliferation and survival of head and neck squamous carcinoma cells.

Authors:  Vlad C Sandulache; Thomas J Ow; Curtis R Pickering; Mitchell J Frederick; Ge Zhou; Izabela Fokt; Melinda Davis-Malesevich; Waldemar Priebe; Jeffrey N Myers
Journal:  Cancer       Date:  2011-01-10       Impact factor: 6.860

Review 5.  Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen.

Authors:  Peter L Pedersen
Journal:  J Bioenerg Biomembr       Date:  2007-06       Impact factor: 2.945

6.  Metabolic alterations in lung cancer-associated fibroblasts correlated with increased glycolytic metabolism of the tumor.

Authors:  Virendra K Chaudhri; Gregory G Salzler; Salihah A Dick; Melanie S Buckman; Raffaella Sordella; Edward D Karoly; Robert Mohney; Brendon M Stiles; Olivier Elemento; Nasser K Altorki; Timothy E McGraw
Journal:  Mol Cancer Res       Date:  2013-03-08       Impact factor: 5.852

7.  Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells.

Authors:  Cedric Gaggioli; Steven Hooper; Cristina Hidalgo-Carcedo; Robert Grosse; John F Marshall; Kevin Harrington; Erik Sahai
Journal:  Nat Cell Biol       Date:  2007-11-25       Impact factor: 28.824

8.  Basic fibroblast growth factor-induced neuronal differentiation of mouse bone marrow stromal cells requires FGFR-1, MAPK/ERK, and transcription factor AP-1.

Authors:  Haijie Yang; Yinyan Xia; Song Qing Lu; Tuck Wah Soong; Zhi Wei Feng
Journal:  J Biol Chem       Date:  2008-01-02       Impact factor: 5.157

9.  STAT3:FOXM1 and MCT1 drive uterine cervix carcinoma fitness to a lactate-rich microenvironment.

Authors:  Lidia Santos Silva; Luis Gafeira Goncalves; Fernanda Silva; Germana Domingues; Valdemar Maximo; Joana Ferreira; Eric W-F Lam; Sergio Dias; Ana Felix; Jacinta Serpa
Journal:  Tumour Biol       Date:  2015-11-12

10.  Fibroblast growth factor-21 enhances mitochondrial functions and increases the activity of PGC-1α in human dopaminergic neurons via Sirtuin-1.

Authors:  Johanna Mäkelä; Timofey V Tselykh; Francesca Maiorana; Ove Eriksson; Hai Thi Do; Giuseppa Mudò; Laura T Korhonen; Natale Belluardo; Dan Lindholm
Journal:  Springerplus       Date:  2014-01-02
View more
  33 in total

Review 1.  Molecular and functional imaging insights into the role of hypoxia in cancer aggression.

Authors:  Samata Kakkad; Balaji Krishnamachary; Desmond Jacob; Jesus Pacheco-Torres; Eibhlin Goggins; Santosh Kumar Bharti; Marie-France Penet; Zaver M Bhujwalla
Journal:  Cancer Metastasis Rev       Date:  2019-06       Impact factor: 9.264

2.  Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment.

Authors:  Tongtong Wei; Jinjing Song; Kai Liang; Li Li; Xiaoxiang Mo; Zhiguang Huang; Gang Chen; Naiquan Mao; Jie Yang
Journal:  J Cancer Res Clin Oncol       Date:  2021-01-02       Impact factor: 4.553

Review 3.  The role of transforming growth factor-beta in immune suppression and chronic inflammation of squamous cell carcinomas.

Authors:  Alexander A Strait; Xiao-Jing Wang
Journal:  Mol Carcinog       Date:  2020-04-17       Impact factor: 4.784

4.  Therapeutic Targeting of FGFR Signaling in Head and Neck Cancer.

Authors:  Zechen Wang; Karen S Anderson
Journal:  Cancer J       Date:  2022 Sep-Oct 01       Impact factor: 2.074

5.  Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity.

Authors:  Peter C Hart; Preety Bajwa; Hilary A Kenny
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 6.  Cancer-associated fibroblasts: overview, progress, challenges, and directions.

Authors:  Qinrong Ping; Ruping Yan; Xin Cheng; Wenju Wang; Yiming Zhong; Zongliu Hou; Yunqiang Shi; Chunhui Wang; Ruhong Li
Journal:  Cancer Gene Ther       Date:  2021-03-12       Impact factor: 5.987

7.  In silico identification of potential inhibitor for TP53-induced glycolysis and apoptosis regulator in head and neck squamous cell carcinoma.

Authors:  Vaishali Chandel; Prem Prakash Sharma; Seema A Nayar; Niraj Kumar Jha; Saurabh Kumar Jha; Brijesh Rathi; Dhruv Kumar
Journal:  3 Biotech       Date:  2021-02-07       Impact factor: 2.406

8.  High glucose induced c-Met activation promotes aggressive phenotype and regulates expression of glucose metabolism genes in HCC cells.

Authors:  Hande Topel; Ezgi Bağırsakçı; Yeliz Yılmaz; Ayşim Güneş; Gülsün Bağcı; Dehan Çömez; Erkan Kahraman; Peyda Korhan; Neşe Atabey
Journal:  Sci Rep       Date:  2021-05-31       Impact factor: 4.379

9.  In vivo detection of distal tumor glycolytic flux stimulated by hepatic ablation in a breast cancer model using hyperpolarized 13C MRI.

Authors:  J Scott Goodwin; Leo L Tsai; David Mwin; Patricia Coutinho de Souza; Svayam Dialani; John T Moon; Zheng Zhang; Aaron K Grant; Muneeb Ahmed
Journal:  Magn Reson Imaging       Date:  2021-04-24       Impact factor: 3.130

10.  Adaptation of the group A Streptococcus adhesin Scl1 to bind fibronectin type III repeats within wound-associated extracellular matrix: implications for cancer therapy.

Authors:  Dudley H McNitt; Soo Jeon Choi; Jessica L Allen; River A Hames; Scott A Weed; Livingston Van De Water; Rita Berisio; Slawomir Lukomski
Journal:  Mol Microbiol       Date:  2019-06-12       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.